Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Funds

Offices

HQ
300 East Business Way
Suite 200
Cincinnati, OH, 45241
USA
Indianapolis, USA
201 North Illinois Street
16th Floor - South Tower
Indianapolis, IN, 46204
USA
Louisville, USA
222 South First Street
Suite 200
Louisville, KY, 40202
USA

People

Co-founder and Managing Partner
Founder & Managing Partner
Managing Partner
Managing Partner
Partner
Partner

Tags

Triathlon Medical Venture Partners

Whether you’re an entrepreneur or a venture capitalist, you’ll find a warm welcome at Triathlon Medical Ventures. Prior to opening our doors in 2004, Triathlon’s team has been investing in life science business opportunities for more than fifteen years. And we are also industry veterans, experienced at growing medical device and biotechnology companies from the inside out - as owners, directors and operational managers.

Triathlon Medical Ventures is a Midwest-based venture capital firm that invests exclusively in the life sciences. We provide equity capital to early and expansion stage companies with proprietary biomedical technology platforms or products addressing significant human healthcare needs.

Recent Milestones

Investments

Company Date Round Size Participants
Aerpio Therapeutics 11/2013Series A$9M6
Akebia Therapeutics 6/2013Series C$41M9
Tolera Therapeutics 10/2012Series B$5.5M3
Aerpio Therapeutics 8/2012Series A$27M6
Juventas Therapeutics 7/2012Series B$22.2M8
Mitralign 5/2012Series D$35M6
Akebia Therapeutics 1/2012Series B$4.1M7
CoLucid Pharmaceuticals 8/2011Venture Round$7.5M5
Akebia Therapeutics 4/2011Series B$22M7
Endocyte 1/2010Series C$26M5
Akebia Therapeutics 9/2009Series A$16M5
BioVex 3/2009Series F$40M7
Tolera Therapeutics 6/2008Series A3
CS-Keys 1/2008Series A$6.25M5

Videos

Sources

  1. Aerpio Therapeutics Completes $9M in Series A Funding (finsmes.com) [edit]
  2. Akebia Therapeutics Completes $41M Series C Financing (finsmes.com) [edit]
  3. Tolera Therapeutics closes Series B-3 financing, raises $5.5 million to submit Phase 3 Special Protocol Assessment for its immune targeting biologic drug in kidney transplantation PR Newswire (prnewswire.com) [edit]
  4. Aerpio Therapeutics Closes $27M Series A Financing (finsmes.com) [edit]
  5. Juventas Therapeutics Closes $22.2M Series B Financing (finsmes.com) [edit]
  6. Mitralign Closes $35M in Series D Financing (finsmes.com) [edit]
  7. Akebia Therapeutics Raises $4.1M in Series B Financing (finsmes.com) [edit]
  8. CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million (prnewswire.com) [edit]
  9. AKEBIA COMPLETES $22M SERIES B FINANCING (akebia.com) [edit]
  10. Endocyte, Inc.: Series C $26M (onbiovc.com) [edit]
  11. Akebia Therapeutics, Inc.: Series A $16M (onbiovc.com) [edit]
  12. BioVex Raises $40 Million (fiercebiotech.com) [edit]
  13. Capital Funding Report [edit]
  14. Ceres Venture Fund Invests in $6.25 Million Series A Round for Cancer-Specific Biomarker Company CS-Keys, Inc. (ceresventurefund.com) [edit]
Edit This Page
Last Edited 1/13/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy